openPR Logo
Press release

Anti-Venom Market by Investment Feasibility, Sales, Production, manufacturers, regions and cost structure and forecast to 2023

02-13-2019 03:25 PM CET | Health & Medicine

Press release from: Market Research Future

Anti-Venom Market

Anti-Venom Market

Anti-Venom Market Highlights

Anti-venom is a purified antibody used against venoms or venom components. In this process, animals are immunized with the venom of a snake, and then antibodies are extracted from it. Anti-venom is the only definitive treatment against snake or scorpion bites.

A number of factors such as the increasing cases of snake bites, increasing government funding, increasing patient pool, unmet medical needs, increasing awareness about antivenoms, and enhancing regulatory framework are boosting the growth of the market.

It is estimated that the anti-venom market is expected to grow at a CAGR of 6.5% during the forecast period of 2017–2023.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/5859

Industry Segmentation

The global anti-venom market is segmented by type, type of species, mode of action, product type, and end-user.

On the basis of type, the global anti-venom market is classified as polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.

On the basis of type of species, the global anti-venom market is classified as snakes, scorpions, spider, and others. The snake segment is further classified as common cobra, common krait, Russell viper, and others.

On the basis of mode of action, the global anti-venom market is classified as cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.

On the basis of product type, the global anti-venom market is classified as snake anti-venom, scorpion anti-venom, spider anti-venom, others.

On the basis of end-user, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Competitive Analysis by Major Key Players

Some of the key players in the global anti-venom market are Allison Medical, Inc., Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Hamilton Company, Hill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Novo Nordisk A/s, Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Thermo Fisher Scientific, UltiMed, Inc., Ypsomed Holding AG, and others.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/anti-venom-market-5859

Comprehensive Regional Analysis

The Americas dominates the anti-venom market owing to the increasing cases of snake bites, and scorpion bites and high healthcare expenditure.

Europe holds the second position in the anti-venom market. The financial support by the government towards research and development and improvement in the reimbursement scenario are expected to drive the European anti-venom market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and the United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.

Asia Pacific is the fastest growing anti-venom market owing to a huge patient pool and rising advancements in pharmaceuticals. According to the Indian Brand Equity Foundation (IBEF), in 2016 the generics market of India stood at USD 26.1 billion. As per the statistics suggested by the World Health Organization (WHO), it has been estimated that around 2.8 million people are bitten by snakes and nearly 46 900 people die from snakebite every year.

The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.

Avail Discount at https://www.marketresearchfuture.com/check-discount/5859

Intended Audience

Pharmaceutical Companies

Research and Development (R&D) Companies

Diagnostic Laboratories

Government Research Institutes

Academic Institutes and Universities

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Venom Market by Investment Feasibility, Sales, Production, manufacturers, regions and cost structure and forecast to 2023 here

News-ID: 1585847 • Views:

More Releases from Market Research Future

Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Due To Due to increasing popularity of Denim jeans, Denim jackets, and other denim apparel.
Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Du …
Denim Market Size Grow at a 75.25 USD Billion in 2025 to 132.4 USD Billion by 2035, CAGR of 5.81% By 2025 - 2035 Global Denim Market is entering a new phase of transformation as consumer demand, fashion cycles, and sustainable innovation continue to reshape the industry. Denim, once considered a classic wardrobe staple, has evolved into a versatile, fashion-driven category supported by innovations in fabric technology, eco-friendly production, and shifting
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% CAGR from 2024
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% …
The global Humanoid Robots Market is projected to reach USD 13.8 Billion by 2032, growing at a robust CAGR of 50.2% during the forecast period from 2024 to 2032. Driven by advancements in artificial intelligence, machine learning, and machine vision, humanoid robots-designed with human-like characteristics-are witnessing widespread adoption across healthcare, education, space exploration, and service industries. These robots are enhancing operational efficiency, performing complex tasks, and improving customer engagement across multiple
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.83 Billion by 2035
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.8 …
The Vertical Farming Market was estimated at USD 7.48 Billion in 2024 and is projected to grow from USD 9.023 Billion in 2025 to USD 58.83 Billion by 2035, exhibiting a robust CAGR of 20.62% during the forecast period from 2025 to 2035. Driven by increasing demand for sustainable agriculture, urbanization, and technological advancements in controlled-environment farming, vertical farming solutions are seeing widespread adoption across commercial, industrial, and urban agriculture sectors. Key
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to Hit USD 476,019.67 Million by 2035
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to H …
The Robotics Market was valued at USD 74,120.70 Million in 2024 and is projected to reach USD 476,019.67 Million by 2035, growing at a robust CAGR of 18.4% during the forecast period from 2024 to 2035. Driven by advancements in medical robots, growing industrial robotics adoption, and the development of AI technologies, robotics solutions are witnessing widespread adoption across healthcare, manufacturing, logistics, and service sectors. Despite challenges like high initial costs

All 5 Releases


More Releases for EUR

Contec S.A. raises EUR 10 million from investor
Contec S.A., a startup recovering industrial raw materials from used tires, has raised EUR 10 million in their latest funding round. These funds will be used to expand the efficiency of Contec's plant (Szczecin, Poland) almost threefold. Two investors are providing the funds: HiTech ASI, the corporate venture capital fund of Bank Gospodarstwa Krajowego, and the Warsaw Equity Group, which is the majority shareholder. Contec S.A. invests in increasing processing
Global Organic Pet Food Market 2020 NewmanEUR(TM)s Own, LilyEUR(TM)s Kitchen, …
Organic Pet Food Market Global and outlook (2015 - 2025) The report published on Organic Pet Food is a invaluable foundation of insightful data helpful for the decision-makers to form the business strategies related R&D investment, sales and growth, key trends, technological advancement, emerging market and more. The global Organic Pet Food market report includes key facts and figures data which helps its users to understand current scenario of the
EUR 155,000 for Safe Zones Project
Eichsfeld Festival Attracts 25,000 Music Fans to Downtown Duderstadt "Tonight is going to rock!" It was with these words that initiators Professor Hans Georg Näder and Peter Maffay opened the 2012 Eichsfeld Festival this past Saturday. Around 25,000 music fans followed the invitation to experience top-class live performances in the Marktstraße of Duderstadt that day. Peter Maffay, Ich + Ich and four regional special guests did more than just wow the
Clariant successfully issues EUR 500 million Eurobond
Muttenz, January 17, 2012 – Today, Clariant successfully priced an Eurobond transaction of EUR 500 million with a tenor of 5 years, issued by Clariant Finance (Luxembourg) S.A. and guaranteed by Clariant Ltd. The fixed rate notes with a minimum denomination of EUR 100,000 and a final coupon of 5 ⅝ % p.a. are maturing on January 24, 2017. The orderbook was significantly oversubscribed on the back of strong investor demand.
VSCloud – cloud services from 0.78 EUR per day
On 15th of August, at a press conference, the unique cloud project named VSCloud was presented which provides cloud services of IaaS (Infrastructure as a Service) type. After three months, VSCloud can boast with hundreds of active users mainly from the Czech Republic and Slovakia. The leadership of VSCloud foresees that the number of first thousand active users will be surpassed by the end of this year. What are the advantages
euNetworks Reports 26% Revenue Rise to EUR 21.7M
London, United Kingdom - 12 November 2009 - euNetworks Group Limited, (SGX: H23.SI), a provider of mission-critical, high-performance networking solutions in Europe, reports a 26% rise in revenue for the nine months ended 30 September 2009 (“9M09”) to €21.7 million, from €17.2 million reported in the corresponding period a year ago (“9M08”). In line with the Group’s efforts at improving its operational efficiencies, gross margin also improved from 42%